<?xml version='1.0' encoding='utf-8'?>
<document id="30567264"><sentence text="Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction between cobicistat and intrabursal triamcinolone."><entity charOffset="10-17" id="DDI-PubMed.30567264.s1.e0" text="steroid" /><entity charOffset="138-151" id="DDI-PubMed.30567264.s1.e1" text="triamcinolone" /><pair ddi="false" e1="DDI-PubMed.30567264.s1.e0" e2="DDI-PubMed.30567264.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30567264.s1.e0" e2="DDI-PubMed.30567264.s1.e1" /></sentence><sentence text="We report a diagnosis of exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction (DDI) between intrabursal triamcinolone and the pharmacokinetic booster cobicistat"><entity charOffset="35-42" id="DDI-PubMed.30567264.s2.e0" text="steroid" /><entity charOffset="154-167" id="DDI-PubMed.30567264.s2.e1" text="triamcinolone" /><pair ddi="false" e1="DDI-PubMed.30567264.s2.e0" e2="DDI-PubMed.30567264.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30567264.s2.e0" e2="DDI-PubMed.30567264.s2.e1" /></sentence><sentence text=" A 53-year-old woman living with HIV, managed with dolutegravir and cobicistat-boosted darunavir, presented to the orthopaedic clinic with worsening hip pain"><entity charOffset="51-63" id="DDI-PubMed.30567264.s3.e0" text="dolutegravir" /><entity charOffset="87-96" id="DDI-PubMed.30567264.s3.e1" text="darunavir" /><pair ddi="false" e1="DDI-PubMed.30567264.s3.e0" e2="DDI-PubMed.30567264.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30567264.s3.e0" e2="DDI-PubMed.30567264.s3.e1" /></sentence><sentence text=" She was diagnosed with greater trochanteric pain syndrome (GTPS) of the hip and was treated with intrabursal injection of bupivacaine and triamcinolone"><entity charOffset="123-134" id="DDI-PubMed.30567264.s4.e0" text="bupivacaine" /><entity charOffset="139-152" id="DDI-PubMed.30567264.s4.e1" text="triamcinolone" /><pair ddi="false" e1="DDI-PubMed.30567264.s4.e0" e2="DDI-PubMed.30567264.s4.e0" /><pair ddi="false" e1="DDI-PubMed.30567264.s4.e0" e2="DDI-PubMed.30567264.s4.e1" /></sentence><sentence text=" Seven days following this injection, she presented with Cushingoid features, an undetectable cortisol and was diagnosed with exogenous steroid-induced hypoadrenalism"><entity charOffset="94-102" id="DDI-PubMed.30567264.s5.e0" text="cortisol" /><entity charOffset="136-143" id="DDI-PubMed.30567264.s5.e1" text="steroid" /><pair ddi="false" e1="DDI-PubMed.30567264.s5.e0" e2="DDI-PubMed.30567264.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30567264.s5.e0" e2="DDI-PubMed.30567264.s5.e1" /></sentence><sentence text=" Cobicistat is a cytochrome P450 3A inhibitor and in this case inhibited clearance of intrabursal triamcinolone, leading to exogenous glucocorticoid excess and adrenal suppression"><entity charOffset="98-111" id="DDI-PubMed.30567264.s6.e0" text="triamcinolone" /><entity charOffset="134-148" id="DDI-PubMed.30567264.s6.e1" text="glucocorticoid" /><pair ddi="false" e1="DDI-PubMed.30567264.s6.e0" e2="DDI-PubMed.30567264.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30567264.s6.e0" e2="DDI-PubMed.30567264.s6.e1" /></sentence><sentence text=" This is the first report to describe this predictable DDI with cobicistat following intrabursal glucocorticoid injection"><entity charOffset="97-111" id="DDI-PubMed.30567264.s7.e0" text="glucocorticoid" /></sentence><sentence text=" This case highlights the complexities in managing non-HIV-related chronic morbidities in people living with HIV" /><sentence text="" /></document>